Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders
Protagenic Therapeutics成功完成了針對壓力相關神經精神疾病的1期試驗的單劑量部分的第三組隊列
Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders
Protagenic Therapeutics成功完成了針對壓力相關神經精神疾病的1期試驗的單劑量部分的第三組隊列
使用瀏覽器的分享功能,分享給你的好友吧